Compared to the CRS group, meloxicam augmented the hippocampal content of Nrf2 and HO-1 by 204.3% (p < 0.01, Tukey post hoc test) and 138.8% (p < 0.05, Tukey post hoc test), respectively. This evidence concerns the gene HMOX1 and congenital rubella syndrome.